Contact Us
Drug Search Results
More Filters [+]

Granotapide

Alternative Names: granotapide, jtt-130, jtt130, jtt 130
Latest Update: 2022-06-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: MTTP Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Akros Pharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Granotapide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Type 2 Diabetes|General Diabetes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
PROMOTE

P2

Completed

General Diabetes

2010-05-06

AT130-G-08-006

P2

Completed

Type 2 Diabetes

2010-05-01

Recent News Events

Date

Type

Title

06/01/2022

PubMed

 Reassessing the multiple values of lowland British floodplains.

12/14/2021

PubMed

 Asylum seekers' and refugees' experiences of accessing health care: a qualitative study.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions